StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv operating margin

Operating margin is operating income as a percentage of revenue.

Pharma-Bio Serv's operating margin for the twelve months ending Jul 31, 2026 was -1.6%. For fiscal 2025 it was -7.1%, against -13.5% the year before. The highest annual figure on record is 19.6% in fiscal 2012.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Oct 31, 2025-7.1%+6.5
FY2024Oct 31, 2024-13.5%−20.1
FY2023Oct 31, 20236.6%+0.5
FY2022Oct 31, 20226.1%+25.2
FY2021Oct 31, 2021-19.2%−29.5
FY2020Oct 31, 202010.3%+1.6
FY2019Oct 31, 20198.7%+15.8
FY2018Oct 31, 2018-7.1%−1.2
FY2017Oct 31, 2017-5.8%−5.4
FY2016Oct 31, 2016-0.5%−8.1
FY2015Oct 31, 20157.6%−2.8
FY2014Oct 31, 201410.4%−8.0
FY2013Oct 31, 201318.4%−1.3
FY2012Oct 31, 201219.6%+2.3
FY2011Oct 31, 201117.3%+11.9
FY2010Oct 31, 20105.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jul 31, 2026-3.1%+12.9
Q2 FY2026CQ1 2026Apr 30, 20265.4%+9.4
Q1 FY2026CQ4 2025Jan 31, 2026-4.1%−0.4
Q4 FY2025CQ3 2025Oct 31, 2025-6.2%+0.4
Q3 FY2025CQ2 2025Jul 31, 2025-16.0%−0.2
Q2 FY2025CQ1 2025Apr 30, 2025-4.1%+9.1
Q1 FY2025CQ4 2024Jan 31, 2025-3.7%+14.7
Q4 FY2024CQ3 2024Oct 31, 2024-6.6%−5.2
Q3 FY2024CQ2 2024Jul 31, 2024-15.8%−25.8
Q2 FY2024CQ1 2024Apr 30, 2024-13.2%−21.5
Q1 FY2024CQ4 2023Jan 31, 2024-18.4%−26.2
Q4 FY2023CQ3 2023Oct 31, 2023-1.4%−8.3
Q3 FY2023CQ2 2023Jul 31, 202310.1%+95.8
Q2 FY2023CQ1 2023Apr 30, 20238.3%+1.1
Q1 FY2023CQ4 2022Jan 31, 20237.8%+2.5
Q1 FY2022CQ4 2021Jul 31, 20226.8%−0.3
Q4 FY2021CQ3 2021Oct 31, 2021-85.7%−88.7
Q3 FY2021CQ2 2021Jul 31, 20217.2%−5.8
Q2 FY2021CQ1 2021Apr 30, 20215.3%−7.5
Q1 FY2021CQ4 2020Jan 31, 20217.1%−4.5
Q4 FY2020CQ3 2020Oct 31, 20203.0%−5.8
Q3 FY2020CQ2 2020Jul 31, 202013.0%+5.7
Q2 FY2020CQ1 2020Apr 30, 202012.8%+3.5
Q1 FY2020CQ4 2019Jan 31, 202011.6%+1.3
Q4 FY2019CQ3 2019Oct 31, 20198.8%+0.1
Q3 FY2019CQ2 2019Jul 31, 20197.3%−8.3
Q2 FY2019CQ1 2019Apr 30, 20199.3%+9.5
Q1 FY2019CQ4 2018Jan 31, 201910.3%+76.7
Q4 FY2018CQ3 2018Oct 31, 20188.8%−0.5
Q3 FY2018CQ2 2018Jul 31, 201815.6%+20.5
Q2 FY2018CQ1 2018Apr 30, 2018-0.2%+8.0
Q1 FY2018CQ4 2017Jan 31, 2018-66.3%−56.9
Q4 FY2017CQ3 2017Oct 31, 20179.3%+19.0
Q3 FY2017CQ2 2017Jul 31, 2017-4.9%−2.4
Q2 FY2017CQ1 2017Apr 30, 2017-8.3%–
Q1 FY2017CQ4 2016Jan 31, 2017-9.5%–
Q4 FY2016CQ3 2016Oct 31, 2016-9.7%–
Q3 FY2016CQ2 2016Jul 31, 2016-2.5%–

More Pharma-Bio Serv figures

See a number that looks wrong?